Showing results (271-280 of 530) with videos related to
Sort By:
Pageof 53
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2020
Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based ScreeningKenneth Offit, Kaitlyn A Tkachuk, Zsofia K Stadler, et al.Archives of Pathology & Laboratory Medicine|August 3, 2022
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal CancerAngela N Bartley, Anne M Mills, Eric Konnick, et al.Human Pathology|December 31, 2016
Diagnosing colorectal medullary carcinoma: interobserver variability and clinicopathological implicationsLik Hang Lee, Rhonda K Yantiss, Eran Sadot, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 23, 2016
Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinomaLik Hang Lee, Marcela S Cavalcanti, Neil H Segal, et al.Patient Education and Counseling|April 1, 2017
A stakeholder-driven approach to improve the informed consent process for palliative chemotherapyAndrea C Enzinger, Jennifer K Wind, Elizabeth Frank, et al.Journal of the American Medical Informatics Association : JAMIA|March 3, 2007
Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicitiesEthan Basch, David Artz, Alexia Iasonos, et al.Journal of Evaluation in Clinical Practice|March 19, 2016
Use of a novel statistical technique to examine the delivery of breast cancer follow-up care by different types of oncology providersHeather B Neuman, Paul J Rathouz, Emily Winslow, et al.Clinical Trials (London, England)|November 7, 2015
Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trialEthan Basch, William A Wood, Deborah Schrag, et al.The American Journal of Managed Care|December 1, 2015
The utility of cost discussions between patients with cancer and oncologistsS Yousuf Zafar, Fumiko Chino, Peter A Ubel, et al.The Oncologist|December 20, 2024
Incidence of patient-reported fatigue developing on palbociclib and endocrine therapy for advanced HR+ HER2- breast cancerShadab A Rahman, Hanneke Poort, Deborah Schrag, et al.Pageof 53